Cytosorbents Corporation
CTSO | NASDAQ
$5.57
+$0.06 (+1.09%)
Sep 22, 2026, 9:41 AM ET · Market open
Market Data
Market Cap $17.31M
Enterprise Value $39.23M
Beta 1.34
Average Volume 81.39K
Shares Outstanding (Diluted) 3.14M
Shares Change YoY -6.49%
Institutional Ownership 26.87%
Exchange NASDAQ
ISIN US23283X2062
Price Performance
Price Change 1M -21.3%
Price Change 3M -35.8%
Price Change 6M -59.0%
Price Change YTD -58.0%
Price Change 1Y -71.5%
Price Change 3Y -86.1%
Price Change 5Y -96.6%
1M CAGR (ann.) -23.5%
1Y CAGR (ann.) -70.5%
5Y CAGR (ann.) -49.8%
All-Time CAGR -21.2%
Valuation
PE Ratio -0.96
Forward PE 15.48
PEG Ratio 0.01
Forward PEG 0.01
PS Ratio 0.47
Forward PS 0.40
PB Ratio -23.05
P/FCF Ratio -1.66
P/Adj. FCF Ratio -1.30
P/OCF Ratio -1.68
EV/Sales 1.05
EV/EBIT -2.53
EV/EBITDA -2.78
EV/FCF -3.76
Earnings Yield -104.4%
FCF Yield -60.2%
Adj. FCF Yield -76.7%
Financial Health
Net Debt $21.92M
Total Debt $26.33M
Cash & Short-Term Investments $4.41M
Total Assets $37.96M
Current Ratio 0.66
Quick Ratio 0.50
Debt / Equity Ratio -35.07
Debt / EBITDA -1.86
Debt / FCF -2.53
OCF / Debt -0.39
Interest Coverage -8.86
Altman Z-Score -12.23
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 71.6%
Operating Profit Margin -33.4%
EBITDA Margin -38.0%
Net Profit Margin -48.9%
FCF Margin -28.0%
Adj. FCF Margin -35.7%
SBC / Revenue 7.7%
SBC Impact (per share) -27.4%
Returns
Return on Assets -48.0%
Return on Equity -445.1%
Return on Invested Capital -42.4%
Return on Capital Employed -89.1%
Return on Tangible Assets -51.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.3%
Revenue CAGR 5Y -3.2%
Revenue CAGR 10Y 20.0%
EPS CAGR 3Y 36.1%
EPS CAGR 5Y 30.9%
EPS CAGR 10Y 2.9%
FCF CAGR 3Y 40.3%
FCF CAGR 5Y 30.2%
FCF CAGR 10Y -4.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 2
EPS Growth Next 3Y 38.0%
Revenue Growth Next 3Y 13.5%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.90
EPS Growth Est (next Q) 2150.0%
Revenue Est (next Q) $9.9M
Revenue Growth Est (next Q) 4.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5.38
Price Target Upside -2.4%
Cash Flow
Operating Cash Flow $-10.31M
Free Cash Flow $-10.42M
Adj. Free Cash Flow $-13.28M
FCF Per Share -$3.32
OCF Per Share -$3.28
OCF/S Ratio -27.7%
Income Statement
Revenue $37.22M
Gross Profit $26.65M
Operating Income $-12.42M
EBITDA $-14.14M
Net Income $-18.21M
EPS (Diluted) -$5.75
Revenue / Employee $249.77K
Profit / Employee $-122.23K
Employees 149
Add to Watchlist
Select watchlists to add or remove CTSO